The long-term objectives of this project are to determine the mechanisms by which interleukin 3 (IL-3) regulates the growth and differentiation of hematopoietic cells. The research focuses on the initial biochemical events that occur following IL-3 binding to its receptor and, based on studies demonstrating the essential role of tyrosine phosphorylation, seek to identify critical substrates of these reactions. Studies during the previous granting period identified a member of the Janus family of cytoplasmic tyrosine kinases, Jak2, as associating with the IL-3 receptor and being activated by IL-3. Studies during the last year demonstrated that the deletion of Jak2 in mice eliminates the response to IL-3. Additional studies indicated that critical biochemical events in IL-3 signaling were dependent upon the recruitment of substrates to the receptor complex through interactions with sites of tyrosine phosphorylation on Jak2. Therefore, during the last year the major sites of tyrosine auto- phosphorylation on Jak2 have been identified. In the proposed studies, we seek to identify the proteins that are recruited to the receptor complex by interaction with sites of tyrosine phosphorylation on Jak2. To accomplish this we propose to use a variety of approaches that have proven to be successful in both my laboratory and in the laboratories of investigators studying other receptor systems. The approaches utilized will include yeast two-hybrid screening, the screening of libraries with phosphopeptides or proteins or the use of affinity columns. From these approaches we have already identified a number of potentially interesting Jak2 associating proteins including JAB1, JAB2, p110delta, PLC-gamma2 and a novel protein. Based on these results we anticipate that a number of additional proteins will be identified. In the second specific aim of this application we propose experiments that seek to determine the significance of the association of these proteins with the IL-3 receptor complex and Jak2. A variety of standard approaches will be used to look at expression patterns, chromosomal localization, cellular localization and approaches to confirm the associations in cells in response to IL-3. Central to our studies however will be the derivation of mice in which the individual genes have been disrupted by homologous recombination in embryonic stem cells. Such mutant mouse strains have already been derived for JAB1, JAB2 and PLC-gamma2 and are being characterized. Together the studies will continue to address fundamental questions regarding the biochemical mechanism by which IL-3 regulates the growth and differentiation of hematopoietic cells as well as potentially providing insights into signal transduction by a wide spectrum of cytokines that utilize receptors of the cytokine receptor superfamily.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK042932-12
Application #
6380660
Study Section
Hematology Subcommittee 2 (HEM)
Program Officer
Badman, David G
Project Start
1990-08-01
Project End
2003-07-31
Budget Start
2001-08-01
Budget End
2002-07-31
Support Year
12
Fiscal Year
2001
Total Cost
$276,773
Indirect Cost
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Gingras, Sebastien; Earls, Laurie R; Howell, Sherie et al. (2015) SCYL2 Protects CA3 Pyramidal Neurons from Excitotoxicity during Functional Maturation of the Mouse Hippocampus. J Neurosci 35:10510-22
Pelletier, Stephane; Gingras, Sebastien; Howell, Sherie et al. (2012) An early onset progressive motor neuron disorder in Scyl1-deficient mice is associated with mislocalization of TDP-43. J Neurosci 32:16560-73
Funakoshi-Tago, Megumi; Pelletier, Stephane; Moritake, Hiroshi et al. (2008) Jak2 FERM domain interaction with the erythropoietin receptor regulates Jak2 kinase activity. Mol Cell Biol 28:1792-801
Gingras, Sebastien; Pelletier, Stephane; Boyd, Kelli et al. (2007) Characterization of a family of novel cysteine- serine-rich nuclear proteins (CSRNP). PLoS One 2:e808
Funakoshi-Tago, Megumi; Pelletier, Stephane; Matsuda, Tadashi et al. (2006) Receptor specific downregulation of cytokine signaling by autophosphorylation in the FERM domain of Jak2. EMBO J 25:4763-72
Pelletier, Stephane; Gingras, Sebastien; Funakoshi-Tago, Megumi et al. (2006) Two domains of the erythropoietin receptor are sufficient for Jak2 binding/activation and function. Mol Cell Biol 26:8527-38
Mead, Paul E; Parganas, Evan; Ohtsuka, Shiro et al. (2005) Evi-1 expression in Xenopus. Gene Expr Patterns 5:601-8
Carpino, Nick; Turner, Steve; Mekala, Divya et al. (2004) Regulation of ZAP-70 activation and TCR signaling by two related proteins, Sts-1 and Sts-2. Immunity 20:37-46
Schuendeln, Michael M; Piekorz, Roland P; Wichmann, Christian et al. (2004) The centrosomal, putative tumor suppressor protein TACC2 is dispensable for normal development, and deficiency does not lead to cancer. Mol Cell Biol 24:6403-9
Carpino, Nick; Thierfelder, William E; Chang, Ming-shi et al. (2004) Absence of an essential role for thymic stromal lymphopoietin receptor in murine B-cell development. Mol Cell Biol 24:2584-92

Showing the most recent 10 out of 72 publications